24/7 Market News- Kraig Biocraft Laboratories Signals Acceleration: Spider Silk Is Coming
Kraig Biocraft Laboratories (OTCQB: KBLB) has achieved several significant milestones in commercializing spider silk production. The company has secured four U.S. trademarks for its SpydaSilk® brand, positioning it for global marketing in luxury performance apparel and textiles.
The company's synthetic biology team has developed what they claim to be the world's largest DNA construct for spider silk production, enabling the engineering of silkworms that can produce stronger fibers with higher yields. Their current BAM-1 production run is expected to exceed their entire 2024 output.
KBLB has expanded its presence in Vietnam's textile corridor with government support and established partnerships. The company's spider silk applications are drawing attention from energy and defense sectors for potential use in ballistic armor, aerospace, and energy-efficient materials.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha raggiunto diversi traguardi significativi nella commercializzazione della produzione di seta di ragno. L'azienda ha ottenuto quattro marchi registrati negli Stati Uniti per il suo marchio SpydaSilk®, posizionandosi per il marketing globale nell'abbigliamento e nei tessuti di lusso ad alte prestazioni.
Il team di biologia sintetica dell'azienda ha sviluppato quello che affermano essere il più grande costrutto di DNA al mondo per la produzione di seta di ragno, consentendo l'ingegnerizzazione di bachi da seta in grado di produrre fibre più forti con rendimenti più elevati. L'attuale produzione BAM-1 dovrebbe superare l'intera produzione prevista per il 2024.
KBLB ha ampliato la propria presenza nel corridoio tessile del Vietnam con il supporto del governo e ha stabilito partnership. Le applicazioni della seta di ragno dell'azienda stanno attirando l'attenzione dei settori energetico e della difesa per un potenziale utilizzo in armature balistiche, aerospaziale e materiali ad alta efficienza energetica.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha logrado varios hitos significativos en la comercialización de la producción de seda de araña. La empresa ha asegurado cuatro marcas registradas en EE. UU. para su marca SpydaSilk®, posicionándose para el marketing global en ropa de lujo de alto rendimiento y textiles.
El equipo de biología sintética de la empresa ha desarrollado lo que afirman ser el constructo de ADN más grande del mundo para la producción de seda de araña, lo que permite la ingeniería de gusanos de seda que pueden producir fibras más fuertes con mayores rendimientos. Se espera que su producción actual BAM-1 supere toda su producción prevista para 2024.
KBLB ha ampliado su presencia en el corredor textil de Vietnam con el apoyo del gobierno y ha establecido asociaciones. Las aplicaciones de seda de araña de la empresa están llamando la atención de los sectores de energía y defensa por su posible uso en armaduras balísticas, aeroespacial y materiales energéticamente eficientes.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 거미줄 생산 상업화에서 몇 가지 중요한 이정표를 달성했습니다. 이 회사는 SpydaSilk® 브랜드에 대해 미국에서 4개의 상표를 확보하여 고급 성능 의류 및 섬유의 글로벌 마케팅을 위한 입지를 다졌습니다.
회사의 합성 생물학 팀은 거미줄 생산을 위한 세계 최대의 DNA 구조체를 개발했다고 주장하며, 이는 더 강한 섬유를 더 높은 수율로 생산할 수 있는 누에의 공학을 가능하게 합니다. 현재의 BAM-1 생산 런은 2024년 전체 생산량을 초과할 것으로 예상됩니다.
KBLB는 정부 지원과 파트너십을 통해 베트남의 섬유 회랑에서 입지를 확장했습니다. 회사의 거미줄 응용 프로그램은 탄도 방탄복, 항공 우주 및 에너지 효율적인 재료에서의 잠재적 사용을 위해 에너지 및 방위 분야의 관심을 끌고 있습니다.
Kraig Biocraft Laboratories (OTCQB: KBLB) a atteint plusieurs jalons significatifs dans la commercialisation de la production de soie d'araignée. L'entreprise a obtenu quatre marques déposées aux États-Unis pour sa marque SpydaSilk®, se positionnant ainsi pour un marketing mondial dans les vêtements de luxe et les textiles de performance.
L'équipe de biologie synthétique de l'entreprise a développé ce qu'elle prétend être la plus grande construction d'ADN au monde pour la production de soie d'araignée, permettant l'ingénierie de vers à soie capables de produire des fibres plus solides avec des rendements plus élevés. Leur production actuelle BAM-1 devrait dépasser l'ensemble de leur production prévue pour 2024.
KBLB a élargi sa présence dans le corridor textile du Vietnam avec le soutien du gouvernement et a établi des partenariats. Les applications de la soie d'araignée de l'entreprise attirent l'attention des secteurs de l'énergie et de la défense pour un usage potentiel dans les armures balistiques, l'aérospatiale et les matériaux écoénergétiques.
Kraig Biocraft Laboratories (OTCQB: KBLB) hat mehrere bedeutende Meilensteine bei der Kommerzialisierung der Spinnenseidenproduktion erreicht. Das Unternehmen hat vier US-Marken für seine Marke SpydaSilk® gesichert und sich damit für das globale Marketing im Bereich luxuriöse Performance-Bekleidung und Textilien positioniert.
Das synthetische Biologieteam des Unternehmens hat das entwickelt, was sie als den weltweit größten DNA-Konstrukt für die Spinnenseidenproduktion bezeichnen, was die Ingenieurtechnik von Seidenraupen ermöglicht, die stärkere Fasern mit höheren Erträgen produzieren können. Der aktuelle BAM-1 Produktionslauf wird voraussichtlich die gesamte Produktion für 2024 übertreffen.
KBLB hat seine Präsenz im Textilkorridor Vietnams mit Unterstützung der Regierung ausgebaut und Partnerschaften etabliert. Die Anwendungen der Spinnenseide des Unternehmens ziehen die Aufmerksamkeit der Energie- und Verteidigungssektoren auf sich, da sie potenziell in ballistischen Rüstungen, der Luft- und Raumfahrt sowie in energieeffizienten Materialien eingesetzt werden könnten.
- Secured four U.S. trademarks for SpydaSilk® brand protection
- Developed largest DNA construct for enhanced spider silk production
- Current BAM-1 production run exceeding entire 2024 output
- Expanding operations in Vietnam with government support
- Growing interest from defense and energy sectors for product applications
- None.
Momentum Builds as Kraig Labs Locks down Branding, Breaks Records, Scales Production, and Gains Global Attention
Denver, Colorado--(Newsfile Corp. - April 10, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB) is no longer a quiet innovator—it's making moves that demand investor attention. Over the past few months, the Company has racked up a series of aggressive milestones, positioning itself at the forefront of commercial spider silk production.
Kraig Labs logo
Recent Milestones and accomplishments can't be ignored.
SpydaSilk® logo
SpydaSilk® Brand Now Fully Trademarked
Kraig secured four registered U.S. trademarks to protect its SpydaSilk® name, logo, and brand assets. With IP fully locked in, the company is now ready to market globally with confidence—particularly in luxury performance apparel and high-grade textiles.
Record-Breaking DNA Construct Redefines What's Possible
Kraig's synthetic biology team completed what's believed to be the world's largest DNA construct ever used for spider silk production. This advancement allows the Company to engineer silkworms capable of producing stronger, targeted fibers at higher yields-paving the way for commercial scalability
Largest BAM-1 Production Batch to Date
Kraig Labs is scheduled to wrap up its current production run, which should surpass its entire 2024 output for BAM-1, its proprietary recombinant spider silk. This operational win confirms that Kraig's infrastructure is ready to meet meaningful market demand.
Vietnamese Media Coverage Underscores Global Expansion
A major news outlet in Vietnam recently profiled Kraig's government-supported activities and growing presence in the region. With partnerships and production operations already underway, Kraig is establishing a stronghold in Asia's textile corridor.
Energy and Defense Sectors Eye Spider Silk Applications
Recent industry analysis highlights the growing interest in spider silk-based applications in ballistic armor, aerospace, energy-efficient materials, and beyond. Kraig's biomaterial platform is increasingly seen as a next-generation solution with cross-sector potential.
Investor Takeaway
The Company has moved beyond R&D and is executing across branding, production, and global positioning.
Biodegradable Spider silk is coming. Kraig Labs is making it real.
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
About 24/7 Market News
24/7 Market News is a leading platform for public company market news. As a pioneer in digital media, we are committed to the rapid dissemination of financial market news and information. We excel in creating innovative public relations campaigns to help our clients effectively reach their target audience. 24/7 Market News offers paid coverage for public companies. For more information or PR inquiries, please contact: sales@247marketnews.com.
Please go to www.247marketnews.com for further information.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/kblb-disclosure/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, the popularity and/or competitive success of the Company's acquired football and other sports teams, the Company's ability to attract players and staff for acquired clubs, unsuccessful acquisitions or other strategic transactions, the possibility of a decline in the popularity of football or other sports, the Company's ability to expand its fanbase, sponsors and commercial partners, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/248081
FAQ
What major trademarks has KBLB secured for its spider silk products?
How does KBLB's latest DNA construct advancement impact spider silk production?
What is the significance of KBLB's current BAM-1 production run?
Which industries are showing interest in KBLB's spider silk applications?
What is KBLB's current expansion status in Vietnam?
